These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30759)

  • 41. Neuroleptic plasma levels and tardive dyskinesia: a possible link?
    Nasrallah HA
    Schizophr Bull; 1980; 6(1):4-7. PubMed ID: 6102792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and epidemiologic aspects of tardive dyskinesia.
    Baldessarini RJ
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):8-13. PubMed ID: 2858483
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of tardive dyskinesia and mania with RBC lithium determinations.
    Ereshefsky L; Rubin TN; Friedman S
    Am J Psychiatry; 1979 Apr; 136(4B):570-3. PubMed ID: 34329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deanol acetamidobenzoate (Deaner) in tardive dyskinesia.
    Stafford JR; Fann WE
    Dis Nerv Syst; 1977 Dec; 38(12 Pt 2):3-6. PubMed ID: 590063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tardive dyskinesia.
    Goetz CG; Klawans HL
    Neurol Clin; 1984 Aug; 2(3):605-14. PubMed ID: 6152483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antipsychotic agents: a review.
    Dilsaver SC
    Am Fam Physician; 1993 Jan; 47(1):199-204. PubMed ID: 8418582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Dose reduction of conventional antipsychotics: does it reduce tardive dyskinesia?].
    van Berkel M; Bogers JP; Bouvy PF
    Tijdschr Psychiatr; 2007; 49(1):37-41. PubMed ID: 17225204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intermittent neuroleptic therapy and tardive dyskinesia: a literature review.
    Goldman MB; Luchins DJ
    Hosp Community Psychiatry; 1984 Dec; 35(12):1215-9. PubMed ID: 6150891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of lithium on an animal model of tardive dyskinesia.
    Klawans HL; Weiner WJ; Nausieda PA
    Prog Neuropsychopharmacol; 1977; 1(1-2):53-60. PubMed ID: 569341
    [No Abstract]   [Full Text] [Related]  

  • 50. Reserpine and tardive dyskinesia.
    Bacher NM; Lewis HA
    Am J Psychiatry; 1984 May; 141(5):719. PubMed ID: 6143509
    [No Abstract]   [Full Text] [Related]  

  • 51. Neuroleptic classification: implications for tardive dyskinesia.
    Hyttel J; Christensen AV; Arnt J
    Mod Probl Pharmacopsychiatry; 1983; 21():49-64. PubMed ID: 6140632
    [No Abstract]   [Full Text] [Related]  

  • 52. The effect of dopamine antagonists in spontaneous and tardive dyskinesia.
    Fog R
    Psychopharmacology Suppl; 1985; 2():118-21. PubMed ID: 2860655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of a subgroup of tardive dyskinesia patients by pharmacologic probes.
    Moore DC; Bowers MB
    Am J Psychiatry; 1980 Oct; 137(10):1202-5. PubMed ID: 6106390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tardive dyskinesia: summary of a Task Force Report of the American Psychiatric Association. By the Task Force on Late Neurological Effects of Antipsychotic Drugs.
    Am J Psychiatry; 1980 Oct; 137(10):1163-72. PubMed ID: 6106389
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacies of agents related to GABA, dopamine, and acetylcholine in the treatment of tardive dyskinesia [proceedings].
    Chien C; Jung K; Ross-Townsend A
    Psychopharmacol Bull; 1978 Apr; 14(2):20-2. PubMed ID: 26102
    [No Abstract]   [Full Text] [Related]  

  • 56. Treatment of tardive dyskinesia with bromocriptine. A test of the receptor modification strategy.
    Lieberman JA; Alvir J; Mukherjee S; Kane JM
    Arch Gen Psychiatry; 1989 Oct; 46(10):908-13. PubMed ID: 2572205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tardive dyskinesia.
    Mackay AV
    Lancet; 1979 Nov; 2(8150):1018-9. PubMed ID: 91747
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of tardive dyskinesia.
    Widroe HJ; Heisler S
    Dis Nerv Syst; 1976 Mar; 37(3):162-4. PubMed ID: 3393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tardive dyskinesia and the behavioral consequences of chronic neuroleptic treatment.
    Gualtieri CT; Guimond M
    Dev Med Child Neurol; 1981 Apr; 23(2):255-9. PubMed ID: 6111511
    [No Abstract]   [Full Text] [Related]  

  • 60. [Tardive dyskinesia: I. Physiopathology and treatment].
    Andrade LA; Bertolucci PH; Pereira JS
    Arq Neuropsiquiatr; 1984 Dec; 42(4):362-70. PubMed ID: 6152578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.